These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 23226721)

  • 1. In vitro profiling of fenofibrate solid dispersion mediated tablet formulation to treat high blood cholesterol.
    Atneriya U; Kapoor D; Sainy J; Maheshwari R
    Ann Pharm Fr; 2023 Mar; 81(2):284-299. PubMed ID: 36037932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design.
    Khatun S; Sutradhar KB
    Front Pharmacol; 2014; 5():137. PubMed ID: 24966835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Characterization of Metformin Hydrochloride - Compritol 888 ATO Solid Dispersion.
    Jagdale S; Patil S; Kuchekar B; Chabukswar A
    J Young Pharm; 2011 Jul; 3(3):197-204. PubMed ID: 21897658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation.
    Adibkia K; Ghajar S; Osouli-Bostanabad K; Balaei N; Emami S; Barzegar-Jalali M
    Adv Pharm Bull; 2019 Jun; 9(2):231-240. PubMed ID: 31380248
    [No Abstract]   [Full Text] [Related]  

  • 5. Formulation and characterization of orodispersible tablet of glimepiride.
    Kinani AAY; Taghi HS
    J Adv Pharm Technol Res; 2022; 13(4):252-260. PubMed ID: 36568054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of processing and sintering on controlled release wax matrix tablets of ketorolac tromethamine.
    Rao MR; Ranpise AA; Thanki KC; Borate SG; Parikh GN
    Indian J Pharm Sci; 2009 Sep; 71(5):538-44. PubMed ID: 20502573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-optimal mixture design inspired modified release tablet formulation of lamotrigine for the treatment of seizures: An in-depth characterization.
    Atneriya U; Sainy J; Chidrawar VR; Sharma M; Maheshwari R
    Ann Pharm Fr; 2024 May; 82(3):446-463. PubMed ID: 37866637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tablet Formulations of Polymeric Electrospun Fibers for the Controlled Release of Drugs with pH-Dependent Solubility.
    Friuli V; Pisani S; Conti B; Bruni G; Maggi L
    Polymers (Basel); 2022 May; 14(10):. PubMed ID: 35632009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Robust Tablet Formulations with Enhanced Drug Dissolution Profiles from Centrifugally-Spun Micro-Fibrous Solid Dispersions of Itraconazole, a BCS Class II Drug.
    Marano S; Ghimire M; Missaghi S; Rajabi-Siahboomi A; Craig DQM; Barker SA
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Dissolution Studies on Solid Dispersions of Mefenamic Acid.
    Rao KR; Nagabhushanam MV; Chowdary KP
    Indian J Pharm Sci; 2011 Mar; 73(2):243-7. PubMed ID: 22303074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of the Hydrophobic Polymeric Coating on 5-ASA Release from the Bipolymeric Milibeads with Amidated Pectin.
    Wójcik-Pastuszka D; Barczyszyn K; Musiał W
    Materials (Basel); 2021 Jul; 14(14):. PubMed ID: 34300842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of febuxostat solid dispersion through screening method.
    Sohn JS; Choi JS
    Saudi Pharm J; 2023 Sep; 31(9):101724. PubMed ID: 37559865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical Characterization and Dissolution Properties of Verapamil. HCI Coprecipitates.
    Goracinova K; Kllsarova L; Simov A
    Drug Dev Ind Pharm; 1995; 21(3):383-391. PubMed ID: 36600540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia.
    Senthilvel CK; Karuppaiyan K; Pothumani A; Vedharethinam A; Jose AW; Muthu Mohamed JM; Sherbiny ME; Ebrahim HA; Shafey ME; Dejene M
    Evid Based Complement Alternat Med; 2022; 2022():4995508. PubMed ID: 35615690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Release Kinetics of a Pharmacologically Active Substance from Model Intra-Articular Implants Replacing the Cruciate Ligaments of the Knee.
    Wojcik-Pastuszka D; Krzak J; Macikowski B; Berkowski R; Osiński B; Musiał W
    Materials (Basel); 2019 Apr; 12(8):. PubMed ID: 31013801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of indomethacin-loaded nanoparticles: effect of polymer matrix and surfactant.
    Dupeyrón D; Kawakami M; Ferreira AM; Cáceres-Vélez PR; Rieumont J; Azevedo RB; Carvalho JC
    Int J Nanomedicine; 2013; 8():3467-77. PubMed ID: 24092971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on in vitro dissolution rate enhancement of indomethacin by using a novel carrier sucrose fatty acid ester.
    Sunil SA; Srikanth MV; Rao NS; Raju V; Murthy KV
    Daru; 2012; 20(1):4. PubMed ID: 23226721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro and in vivo investigation into the suitability of compression coated tablets of indomethacin for the treatment of rheumatoid arthritis which follow circadian rhythms.
    Songa AS; Meka VS; Nali SR; Kolapalli VR
    Drug Dev Ind Pharm; 2013 Mar; 39(3):447-56. PubMed ID: 22380574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vitro evaluation of ibuprofen mouth dissolving tablets using solid dispersion technique.
    Jain SK; Shukla M; Shrivastava V
    Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1037-42. PubMed ID: 20686256
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.